Thailand vs United States of America: Proportion of isolates with decreased susceptibility or resistance
Thailand
0.4587
in 2018
United States of America
0.2907
in 2018
Thailand rank
21st
United States of America rank
23rd
Proportion of isolates with decreased susceptibility or resistance over time
- Thailand
- United States of America
How they compare
Thailand currently reports 0.4587 against 0.2907 in United States of America, a difference of 0.168.
That makes Thailand's figure about 1.6 times United States of America's.
The two have swapped places 5 times across 10 shared years of data; in 2009 it was United States of America ahead.
Thailand ranks 21st and United States of America ranks 23rd of 51 countries.
Across the 2 decades both report, Thailand averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Thailand | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.7993 | 0.7993 | United States of America |
| 2010s | 2.35 | 0.4084 | 1.94 | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Thailand or United States of America?
- Thailand, at 0.4587 against 0.2907 in United States of America as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Thailand and United States of America?
- 0.168, with Thailand ahead.
- How many years of comparable data are there for Thailand and United States of America?
- 10 years are reported by both, from 2009 to 2018.
- How do Thailand and United States of America rank globally for proportion of isolates with decreased susceptibility or resistance?
- Thailand ranks 21st and United States of America ranks 23rd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.